Company: BSX
Filing Date: 2025-02-18
Form Type: S-3ASR
Source: 0001104659-25-014808
Chunk: 0

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-02-18
Form: S-3ASR
Chunk 0
---
TABLE OF CONTENTS

As filed with the Securities and Exchange Commission on February 18, 2025 Registration No. 333- UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form S-3 REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933 Boston Scientific Corporation (Exact name of Registrant as specified in its charter)

| ​ | Delaware                                                        
 (State or other jurisdiction of incorporation or organization)​ | ​ | ​ | 04-2695240                           
 (I.R.S. Employer Identification No.) | ​ |

300 Boston Scientific Way
Marlborough, Massachusetts 01752-1234
Telephone: (508) 683-4000 (Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices) American Medical Systems Europe B.V. (Exact name of Registrant as specified in its charter)

| ​ | The Netherlands                                                 
 (State or other jurisdiction of incorporation or organization)​ | ​ | ​ | 98-1283032                           
 (I.R.S. Employer Identification No.) | ​ |

Vestastraat 6
6468 EX Kerkrade
The Netherlands
Telephone: +31-455467700 (Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices) Vance R. Brown, Esq.
Boston Scientific Corporation
300 Boston Scientific Way
Marlborough, Massachusetts 01752-1234
Telephone: (508) 683-4000 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copy to: Richard B. Alsop, Esq.
Erika Kent, Esq.
Allen Overy Shearman Sterling US LLP
599 Lexington Avenue
New York, New York 10022-6069
Telephone: (212) 848-4000 Approximate date of commencement of proposed sale to the public : From time to time after the effective date of this registration statement. If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐ If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, please check the following
box. ☒ If